Thursday, June 17, 2021
News

Double-mutant variant shows enhanced host cell entry, immune evasion

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

London | May 8, 2021 3:48:56 PM IST
Double-mutant variant of severe acute respiratory syndrome SARS-CoV-2 -- B.1.617 -- that has emerged in India, entered certain types of lung and intestine cells with slightly increased efficiency compared with the original wild-type strain, say researchers.

The researchers, including Markus Hoffmann from German Primate Center, also reported that the entry of B.1.617 into the lung and intestinal cells was blocked following treatment with soluble angiotensin-converting enzyme 2 (ACE2) or the serine protease inhibitor Camostat.

However, this host cell entry was not blocked by the monoclonal antibody Bamlanivimab, which has received emergency use authorisation (EUA) as a Covid-19 treatment.

Finally, B.1.617 also partially evaded neutralisation by the antibodies induced through natural infection or immunisation with the Pfizer-BioNTech BNT162b2 vaccine, a study that appeared in the pre-print repository medRxiv, suggested.

The researcher said that antibody evasion by B.1.617 may contribute to the rapid spread of this variant.

The sharp rise in Covid-19 cases and deaths in India over recent weeks is thought to be caused by the novel variant B.1.617, which harbours eight mutations in the spike protein.

These include the RBD mutations L452R and E484Q, which are known to modulate antibody-mediated neutralisation.

However, the researchers said it is not currently known whether B.1.617 resists this antibody-mediated neutralization.

To test whether B.1.617 is more adept at entering cells, the researchers infected eight cell lines with pseudotyped virus particles expressing spike protein from the original wild-type virus, the B.1.617 variant, or the B.1.351 variant.

Of the eight cell lines tested, the spikes of B.1.617 and B.1351 mediated entry into Calu-3 lung cells and Caco-2 colon cells with slightly increased efficiency, compared with the original strain.

Collectively, the study reveals that antibody evasion by B.1.617 may contribute to the rapid spread of this variant, the team noted.

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
Andhra logs 6K new Covid cases, tally 18...
Bangladesh extends Covid-19 restrictions...
UK reports highest daily increase of Cov...
Raj becomes fourth state to inoculate 2 ...
Bengaluru's Covid tally crosses 12-lakh ...
Reasi first J&K district with zero Covid...
More...
 
INDIA WORLD ASIA
'Infringement of liberty': SC shocked as...
Man held by NCB Mumbai for providing bit...
Fertiliser subsidy scam: RJD's AD Singh ...
Two die, two critical after consuming su...
Chirag did not agree to LJP contesting B...
Punjab Congress MP summoned for casteist...
More...    
 
 Top Stories
Myanmar village of Kin Ma burns dow... 
Putin lashes out at US after meetin... 
COVID-19 vaccines Myth vs Facts... 
TTK Prestige launches innovative Sl... 
Learning in the 'New Normal'... 
Delhi Court grants bail to man accu... 
Parts of Delhi receives heavy rains... 
MK Stalin to meet PM Modi today, re...